Biosimilars Market Size And Share

  • Report Code : TIPHE100001246
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 223
Buy Now

Biosimilars Market Size, Share, and Forecast by 2028

Buy Now

Biosimilars Market Report Biosimilars Market Scope and Analysis Biosimilars Market Size and Share

Biosimilars Market: Strategic Insights

Biosimilars Market

  • CAGR (2021 - 2028)
    34.8%
  • Market Size 2021
    US$ 18.44 Billion
  • Market Size 2028
    US$ 136.07 Billion

Market Dynamics

GROWTH DRIVERS
  • Rising demand for biosimilars due to cost-effectiveness
  • Expanding use of biosimilars in oncology and immunology
FUTURE TRENDS
  • Growing adoption of biosimilars
  • Support for biosimilar approvals
OPPORTUNITIES
  • Adoption of biosimilars to lower healthcare costs
  • Expansion into emerging markets with biosimilar drugs

Key Players

  • Biocon Ltd
  • Sanofi Aventis
  • Celltrion Inc
  • Amgen Inc
  • Pfizer Inc
  • Samsung Bioepis
  • Sanofi SA
  • Coherus BioSciences Inc
  • Dr Reddy

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Disease Indication
  • Cancer
  • Diabetes
  • Autoimmune Diseases
  • Other Disease Indications
Drug Class
  • Granulocyte Colony-Stimulating Factor
  • Insulin
  • TNK Blockers & Monoclonal Antibodies
Route of Administration
  • Intravenous
  • Subcutaneous
End User
  • Hospital
  • Specialty Clinics
  • Homecare